Posts in Legislation

The patent market had an amazing bull run from the late 1980’s through 2012. The peak was 2011 to 2012 when we saw a number of multi-billion dollar patent sales and patent-driven acquisitions. The patent market started slowing down substantially shortly thereafter. Many blame the America Invents Act (AIA), which introduced a variety of ways to inexpensively challenge the validity of patents in administrative proceedings at the patent office. All of a sudden the confidence that once a patent was issued it was valid was shaken. However, the AIA was only part of the problem.

Fears about trade secret trolls are based in mythology, not on fact. If those claiming federal trade secret legislation would lead to trade secret trolls actually understand trade secret law they simply couldn’t possibly come to a conclusion that there is any risk there will be a single trade secret troll, let alone some kind of zombie-like rise. Simply stated the fear is pure fiction. In addition to seeing absolutely no evidence of trade secret trolls on the State level, trade secrets require a relationship or some nexus between the parties to the dispute. You simply cannot commoditize trade secret litigation in the same way patent trolls can and do commoditize patent litigation.

With so much brash bluster, it was inevitable that Cuban would argue himself into a corner eventually. It finally looks like Cuban’s shoot from the mouth first approach is exposing him as something of a patent hypocrite. More specifically, Mark Cuban recently made threatening comments toward Wal-Mart Stores Inc. (NYSE:WMT), threatening the retail giant with a patent infringement lawsuit of his own. It would seem that Cuban, like so many others who so loudly want patent reform, have an exceptionally dim view of your patents, but his patents are rock solid and deserve to be respected. Such hypocrisy is not new in the patent reform debate, but it is extremely telling.

The USPTO has released its ‘Report on Confirmatory Genetic Diagnostic Testing,’ which was prepared to fulfill the requirements of §27 of the Leahy-Smith America Invents Act. The USPTO did make an interesting observation that has been reflected in its patent examining guidelines. The USPTO Report concludes that ‘it is unlikely that exclusive provision of a diagnostic test, whether for an original diagnosis or to confirm the original result, will be possible based on patenting and licensing behavior.’ This statement reinforces the USPTO’s prior broad interpretations of the Court’s findings in Mayo and Myriad. Of note is that in the USPTO Report, the USPTO adopts the Supreme Court’s factually and scientifically unsupported distinction between genomic DNA and cDNA.

Yesterday I moderated a Google Hangout on the topic of patent reform, which was sponsored by the Innovation Alliance’s save the inventor campaign. Joining me for the conversation was United States Senator Chris Coons (D-DE), a member of the Senate Judiciary Committee and the driving force behind the STRONG Patents Act, and Congressman Thomas Massie, an inventor and patent owner who is a member of the House Science, Space and Technology Committee. Our wide ranging conversation addressed whether patents promote or inhibit innovation, the most problematic provisions in the pending patent reform bills, whether patent reform is even necessary, and the inevitable reality that a push for patent reform will remain on the agenda for the foreseeable future.

3D printed human organs are coming increasingly close to being a reality according to several reports. In addition to potentially saving thousands of lives every year, this ground-breaking technology raises issues related to patent law that cannot be ignored. Are human organs and/or tissues that are created through 3D printing process that use naturally-occurring cells eligible for patenting? Or are such organs and tissues considered to be products of nature and therefore ineligible for patenting? The America Invents Act (AIA) creates serious questions, as do some recent Supreme Court ruling on patent eligibility.

On Wednesday, October 7, 2015, I will have the honor of interviewing Senator Chris Coons (D-DE) and Congressman Thomas Massie (R-KY) in a live, bipartisan online Google Hangout. Our conversation will discuss pending patent legislation, specifically addressing concerns with the PATENT Act (S. 1137) and the Innovation Act (H.R. 9), which are currently pending in Congress.

Earlier today U.S. Senator Chris Coons (D-DE) introduced legislation to encourage and increase the use of crowdsourcing and citizen science within the federal government. The purpose of the legislation is to advance and accelerate scientific research, literacy, and diplomacy. There are not a lot of specifics in the bill, but the bill would authorize the head of each Federal agency to “utilize crowdsourcing and citizen science approaches to conduct activities designed to advance the mission of the respective Federal agency or the joint mission of Federal agencies, as applicable.”

Will House Freedom Caucus members be conservative on patent reform, or will conservatives continue to support the Obama/Google patent reform agenda? Ironically, while Speaker Boehner has been criticized by conservatives as being a Republican in name only (RINO), several of the members of the House Freedom caucus who serve on the House Judiciary Committee have been anything but conservative on certain votes. For example, when it comes to patent reform at least some self professed Congressional conservatives have decided to side with the Obama Administration, giving Obama corporate supporters everything they want from patent legislation.

you continually hear from Members of Congress, Staffers and those giant companies pushing for weaker patents that the goal of the bill is nothing more than to keep small business owners from getting sued for using pieces of equipment that they purchased. The truth, however, is far different. The small businesses that Congress claims they want to protect are just political pawns in a much larger game of chess. The people funding the effort to enact further patent reform are not small businesses; rather they are Google, Cisco, J.C. Penney, and other giant corporations. The interests important to these giant corporations are driving the push for more reform, not a deep-rooted concern for the plight of American small businesses.

The stark reality of how government operates leaves us with a patent system that will be perpetually on the brink. Giant corporations have become effectively insulated from any consequences associated with stealing patented innovations, yet they continually want more and more help from Congress, which they dress up and roll out as “reform.” Even if they fail this time these companies will return, with more lobbyists and special interest groups demagoguing innovators as inherently evil, Satan practically. Rather than recognize the critical role patents play in the innovation ecosystem and in the U.S. economy, Congress is poised to flush the patent system down the drain because there are a handful of giant tech corporations that believe they would benefit.

Unlike Big Bear Lake, which will collect the runoff snowfall or rain, much of the rest of southern California is ill equipped to take advantage of El Niño rains. Those familiar with southern California will know that in beach towns there are signs on or near drains warning people not to dump things into the gutter because whatever goes into the drain will be released into the ocean. That, of course, also means that water that falls in beach communities in southern California will not be collected, or even useful. Due to perpetual poor government planning, even if El Niño does drop large amounts of rain water on southern California much of it will simply wind up in the ocean.

Like a lemming running off a cliff, Fortune author Jeff John Roberts ignores easily verifiable historical truths in what can really only be described as a hit piece on the patent system and patents in general. The lack of intellectual integrity, or even intellectual curiosity, is astonishing… It is absolutely necessary to quash any suggestion that here is a “short supply” of medical miracles today. Medical research is still turning up incredible findings. A quick scan of health news shows plenty of academic innovation leading to tomorrow’s medical miracles. That the author could make such an utterly absurd statement has to call into question the broader motivations. Of course, authors do unfortunately sometimes exaggerate, misrepresent and even lie. What is truly astonishing is how the Editors of Fortune allowed such a falsehood to be published. Do they do no fact checking at all at Fortune?

I will moderate what should be a lively discussion on the PTAB and inter partes review. I will be joined by Erich Spangenberg, advisor to Kyle Bass and the person some have described as “the most notorious patent troll in America.” Also joining me will be Q. Todd Dickinson, former Director of the United States Patent and Trademark Office and current partner at Novak, Druce. Among other things we will discuss: (1) What will become of the Kyle Bass IPR petitions? (2) USPTO proposed rule changes and pilot programs (3)
Is Congress likely to legislatively reform IPRs?

By May 22, 2015, Congressman Goodlatte scheduled at least three $1,000 a plate breakfasts for wavering Judiciary Committee Conservatives. Money made at these breakfasts went directly to the Conservative’s campaign coffers. While not directly stated, the timing of the breakfasts suggest they might have been intended to influence their vote on patent reform. The secret to maximizing lobbyist donations is to guarantee the proper bang for the buck. For this reason, Goodlatte, whose rank and power matter to crafting legislation favorable to donors, attended these breakfasts personally, allowing his name to be used in order to ensure a larger turnout.